In view of contradictory reports on the growth hormone dependency ofearly postnatal growth we studied the growth curves of 15 infants with neonatal growth hormone deficiency. In seven infants the growth curve was paraliel to
ciencies, as a consequence ofeither hypothalamic or pituitary disease.2 3 There are few data on the growth pattern of infants with neonatal growth hormone deficiency. In most studies the data on length are scarce, but the observation that some children with documented growth hormone deficiency grow well in the first year of life2' has led several authors to state that growth in the first six months of life may be growth hormone independent.5 6 This concept has been used to provide a biological basis for the so called infancy-childhood-puberty (ICP) growth model which breaks down normal linear growth mathematically into three additive and partly superimposed components. The infant component is believed to be independent of growth hormone. 4 5 However, when the available case reports are scrutinised it appears that some infants were already short in length after gne month or just a few months,' 2 7 8 and in a series of 14 infants 50% are reported as having immediate growth retardation. 9 In order to clarify this apparent discrepancy we decided to study the growth pattern from birth to three years of age in all growth hormone deficient patients who presented shortly after birth with varying combinations of hypoglycaemia, prolonged jaundice, and micropenis.
Patients and methods All patients with neonatal pituitary deficiency including growth hormone deficiency who presented to our clinic over the previous 10 years were included, provided that sufficient growth data were available over the first nine months of life. We chose to include only those and 9 months of age (corrected for gestational age) are shown in table 2. Both groups were similar in the occurrence of associated deficiencies and of presenting signs (table 1) , but five out of seven infants in group 1 were born in breech or transverse position compared with one out of eight in group 2. With two exceptions, all patients had deficiencies of hypothalamic origin shown by an increased and delayed TSH response to TRH. The two patients with a total pituitary growth hormone deficiency had also a total prolactin deficiency and partial TSH deficiency. ' These patients and two patients with a total growth hormone deficiency of hypothalamic origin detected at 2 weeks of age all belonged to group 2 (length SD score at 9 months between -7-2 and -5-3).
In two infants in group 1, two consecutive arginine tests were performed at 1-2 months and at 3-13 months showing a decreasing growth hormone peak over time (18 to patients who were certainly completely growth hormone deficient at birth showed an immediate growth retardation, providing evidence that growth hormone is necessary for early postnatal growth. This observation is in line with the findings of Tanner. 2 13 While the ICP model appears to be a useful mathematical model to describe postnatal growth, the infancy and childhood components should not be associated with a growth hormone independent and growth hormone dependent growth phase, respectively.
If growth hormone is necessary for early postnatal growth, the question arises whether it might play some part in prenatal growth. So far, most authors concur that it is not necessary for prenatal growth and that insulin and insulinlike growth factors promote prenatal growth. '4 In contrast, we have shown that five out of 15 infants had a birth length of less than -2 SD and the mean birth length was - [ 7 and -[-3 in the two groups. However, when all reported cases were studied, there was no infant with a birth length of less than -2 SD out of the 10 birth length measurements reported,2 8 15-9 although a birth weight of less than 2500 g was encountered in five out 34 neonates. Recently, the study of a large database revealed that the number of infants with a short birth length was higher than statistically expected.20 On the basis of these data it is uncertain whether growth hormone plays a part in prenatal growth and it seems more likely that the low mean birth length is caused by the additional pituitary deficiencies or by other factors not directly related to the pituitary deficiencies. All five infants with a short birth length had additional TSH and ACTH deficiencies, but this combination was also seen in the majority of the infants with normal birth lengths.
In agreement with previous studies,' 2 we have shown that hypoglycaemia, prolonged jaundice, and micropenis are important clinical clues to the presence of hypothalamic pituitary dysfunction in the neonate. Treatment with hydrocortisone (6-12 mg/m2/day) was in most cases sufficient to prevent further attacks of hypoglycaemia if the parents were instructed appropriately about increasing the dosage during stress. The micropenis could be treated successfully with three intramuscular injections of 25 mg testosterone esters (Sustanon, Organon).
In conclusion, this s-tudy shows that growth hormone exerts a significant influence on linear growth from birth onwards and possibly even from before birth, in contrast to earlier reports and to the assumptions made in the ICP model.
Pain relief
What does a baby think when he (she) experiences pain? Does a baby experience pain or does he react to it in a reflex fashion? Does pain make a baby unhappy? Does the psychological repertoire of the newborn include happiness and unhappiness? How many angels can pirouette on a pin head?
I have referred briefly in the past (Archivist 1991: 1032) to the need for adequate analgesia for babies, quoting the work of Anand and Aynsley-Green. There seems no doubt that in the past we have all failed the babies under our care in this respect, perhaps being unduly influenced by concern about possible adverse effects of analgesia and perhaps by unanswerable philosophical speculations.
If there was any doubt remaining about the necessity for adequate analgesia for small babies it should be dispelled by another report from Dr Anand, this time with Dr P R Hickey, on work done in Boston, Massachusetts (New England Journal of Medicine 1992;326:1-9). In a prospective, randomised trial they measured hormonal and metabolic responses to cardiac surgery in 45 newborn babies, comparing two different methods ofanaesthesia and analgesia. Fifteen babies received 'light anaesthesia and analgesia' with halothene, ketamine, pancuronium, and intravenous morphine during the operation and repeated morphine and diazepam postoperatively. The other 30 were given 'deep opiate anaesthesia and analgesia' using a continuous infusion of fentanyl or sufentanil and pancuronium as required. In response to surgery the babies given sufentanil produced less insulin and more adrenaline, noradrenaline, I 1 endorphin, glucagon, corticosteroids, and aldosterone than those given halothane and morphine. Blood glucose, lactate, and acetoacetate concentrations rose to higher values in the halothane group. The chemical measurements, therefore, gave evidence of an increased stress response in the 'light anaesthesia' group. The sufentanil group also did better in terms of clinical outcome. There were no postoperative deaths in this group (n= 30) but four in the halothane group (n= 15). After the study mortality from open heart surgery in the Boston Children's Hospital was reduced by more than 60%. Morbidity too was significantly less in the sufentanil group in which postoperative sepsis, necrotising enterocolitis, disseminated intravascular coagulation, and metabolic acidosis did not occur whereas each of these complications occurred in 20% or more of babies in the halothane group.
So adequate anaesthesia and analgesia for babies is-not only humane in that it prevents pain, it also reduces mortality and morbidity. Babies are people and people need adequate pain relief.
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